Literature DB >> 20140606

Effect of cibenzoline on biventricular pressure gradients in a pediatric patient with hypertrophic obstructive cardiomyopathy.

Takamichi Ishikawa1, Satoru Iwashima, Takehiko Ohzeki.   

Abstract

This report presents the case of an 8-year-old male with biventricular hypertrophic obstructive cardiomyopathy who achieved a successful reduction of the pressure gradients by treatment with cibenzoline. Ultrasound echocardiography showed marked intraventricular septal hypertrophy and left midventricular and right ventricular outflow obstructions. A cardiac catheterization revealed left midventricular and right outflow obstructions associated with pressure gradients of 100 and 35 mmHg, respectively. An intravenous injection of 28 mg (1.4 mg/kg) cibenzoline immediately improved the biventricular pressure gradients. Therefore, oral cibenzoline treatment was initiated, the dose was increased to 150 mg/day, and both pressure gradients remained low, without any complications at the time of discharge, 4 months later.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20140606     DOI: 10.1007/s00246-010-9651-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  15 in total

1.  Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study.

Authors:  Alan W Nugent; Piers E F Daubeney; Patty Chondros; John B Carlin; Steven D Colan; Michael Cheung; Andrew M Davis; C W Chow; Robert G Weintraub
Journal:  Circulation       Date:  2005-08-22       Impact factor: 29.690

2.  Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.

Authors:  M Hamada; Y Shigematsu; S Ikeda; Y Hara; H Okayama; K Kodama; T Ochi; K Hiwada
Journal:  Circulation       Date:  1997-09-02       Impact factor: 29.690

3.  Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide.

Authors:  C Pollick
Journal:  N Engl J Med       Date:  1982-10-14       Impact factor: 91.245

4.  Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment.

Authors:  D A Theodoro; G K Danielson; R H Feldt; B J Anderson
Journal:  J Thorac Cardiovasc Surg       Date:  1996-12       Impact factor: 5.209

5.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

Authors:  B J Maron; S A Casey; L C Poliac; T E Gohman; A K Almquist; D M Aeppli
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

6.  Echocardiographic assessment of right ventricular obstruction in hypertrophic cardiomyopathy.

Authors:  Masatoshi Shimizu; Hiroya Kawai; Yoshiyuki Yokota; Mitsuhiro Yokoyama
Journal:  Circ J       Date:  2003-10       Impact factor: 2.993

7.  Attenuation of biventricular pressure gradients by cibenzo-line in an 18-year-old patient with hypertrophic obstructive cardiomyopathy.

Authors:  Go Hiasa; Mareomi Hamada; Yuji Shigematsu; Yuji Hara; Tomoaki Ohtsuka; Akiyoshi Ogimoto; Hideyuki Saeki; Jun Suzuki; Tsuyoshi Matsunaka; Hironobu Hamada; Takafumi Okura; Kunio Hiwada
Journal:  Circ J       Date:  2002-12       Impact factor: 2.993

8.  Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.

Authors:  Martin S Maron; Iacopo Olivotto; Sandro Betocchi; Susan A Casey; John R Lesser; Maria A Losi; Franco Cecchi; Barry J Maron
Journal:  N Engl J Med       Date:  2003-01-23       Impact factor: 91.245

9.  Inhibition of the myocardial Ca2+ inward current by the class 1 antiarrhythmic agent, cibenzoline.

Authors:  M Holck; W Osterrieder
Journal:  Br J Pharmacol       Date:  1986-04       Impact factor: 8.739

10.  Hypertrophic cardiomyopathy in infants: clinical features and natural history.

Authors:  B J Maron; A J Tajik; H D Ruttenberg; T P Graham; G F Atwood; B E Victorica; J T Lie; W C Roberts
Journal:  Circulation       Date:  1982-01       Impact factor: 29.690

View more
  1 in total

1.  Mid-term outcomes of biventricular obstruction and left ventricular outflow tract obstruction after surgery correction in child and adolescent patients with hypertrophic cardiomyopathy.

Authors:  Shanshan Zhai; Haitao Xu; Chaomei Fan; Yinjian Yang; Fei Hang; Xiying Guo; Hongyue Wang; Fujian Duan; Jun Yan
Journal:  PLoS One       Date:  2018-02-06       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.